from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1395/-

LFCtreatmentdescriptionclass of inhibitor

-0.247

Amikacinug/mL Amikacintranslation

-0.236

Cap5-10ug/mL Capreomycintranslation

-0.615

Rox10-50 ug/mL Roxithromycintranslation

0.216

SM2-5 ug/mL Streptomycintranslation

0.387

Tet5-10 ug/mL Tetracyclinetranslation

0.193

Rif0.2-5ug/mL Rifampicintranscription

-0.239

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.140

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.486

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.357

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.305

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.253

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.990

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.140

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.826

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.026

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.074

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.272

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.200

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.055

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.015

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.081

Nigericin50 uM Nigericinrespiration

0.037

TRC10-150 ug/mL Triclosanrespiration

-0.155

TRZ10-25 ug/mL Thioridazinerespiration

1.515

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.291

menadione6-10 ug/mL Menadionerespiration

-0.193

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.237

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.129

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.727

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

3.053

NRP_1Non-replicating persistence stage 1dosRassociated

-0.235

Amp0.2mg/mL AmpicillincellWall

-0.281

Cephalexin20-100 ug/mL CephalexincellWall

0.438

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.170

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.008

EMB10-20 ug/mL EthambutolcellWall

-0.275

Eta12-40 ug/mL EthionamidecellWall

-0.323

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.298

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.614

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.314

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.715

BZA0.12 mg/mL BenzamidearomaticAmides

-0.534

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.622

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.129

H2O24 mM hydrogen peroxideDNAdamaging

-0.002

Levo10 ug/mL LevofloxacinDNAdamaging

-0.495

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.519

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.136

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.234

UVUV-irradiationDNAdamaging

0.774

ARP41-4 ug/mL Antitubercular compound ARP4?

0.110

Antimycin12.5-50 ug/mL Antimycin A?

-0.521

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.045

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.233

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.318

PA8240.2-2 ug/mL PA-824?

2.073

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.013

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.534

Verapamil50 uM Verapamil?

-0.438

mercaptoethanol2 mM 2-Mercaptoethanol?

0.033

methoxatin10-20 ug/mL Methoxatin?